As the U.S. Food and Drug Administration’s Center for Veterinary Medicine continues to progress in implementation of its Animal and Veterinary Innovation Agenda, the center is supporting a collaborative agreement to the Reagan-Udall Foundation for the FDA (the Foundation) to conduct a strengths, weaknesses, opportunities, and threats (SWOT) analysis. This SWOT analysis aims to research the […]
Category Archives: FDA
FDA Announces Animal and Veterinary Innovation Centers Partnerships
The U.S. Food and Drug Administration’s Center for Veterinary Medicine is announcing today the establishment of four Animal and Veterinary Innovation Centers (AVICs), which are the recipients of funding for work to advance regulatory science and further development of innovative products and approaches to better support animal health and veterinary interventions. These AVICs further the […]
Veterinarian-Client-Patient Relationships, Prescribing/Dispensing Animal Drugs and Telemedicine
The FDA has received questions from interested parties about Federal requirements related to a veterinarian’s role in dispensing prescription animal drugs and to the establishment of a veterinarian-client-patient relationship (VCPR) in the course of practice. The following Q&As only cover the veterinarian’s obligations under Federal law. Veterinarians should also consult their state licensing boards to […]
FDA Finalizes Guidance to Provide Further Clarity on Veterinary Feed Directives
Today, the U.S. Food and Drug Administration finalized Guidance for Industry (GFI) #120: Veterinary Feed Directive Regulation Questions and Answers to assist stakeholders involved with veterinary feed directives (VFDs) – veterinarians, VFD feed distributors (medicated feed mills, feed retailers) and clients (owners or other caretakers of the animals) – in complying with the Veterinary Feed Directive (VFD) final rule that published in 2015.
Comment Now: FDA Proposes New Regulations for Animal Drug Labeling
Today the U.S. Food and Drug Administration is proposing new regulations to provide animal drug sponsors with predictable requirements for the labeling of prescription and over-the-counter new animal drugs, as well as new animal drugs for use in animal feeds. The proposed content and format of labeling would also benefit veterinarians, animal owners, and animal producers by providing a more consistent presentation of information on the safe and effective use of these new animal drugs.
Comment Now: FDA Proposes New Regulations for Animal Drug Labeling
Today the U.S. Food and Drug Administration is proposing new regulations to provide animal drug sponsors with predictable requirements for the labeling of prescription and over-the-counter new animal drugs, as well as new animal drugs for use in animal feeds. The proposed content and format of labeling would also benefit veterinarians, animal owners, and animal producers by providing a more consistent presentation of information on the safe and effective use of these new animal drugs.
For Comment: FDA Releases Draft Guidance on Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals
Open for Public Comment: FDA Draft Guidance on Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals
For Comment: FDA Releases Draft Guidance on Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals
Open for Public Comment: FDA Draft Guidance on Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals
FDA Releases Plan for Supporting Antimicrobial Stewardship in Veterinary Settings for FY 2024-2028
The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) released, “Supporting Antimicrobial Stewardship in Veterinary Settings, Goals for Fiscal Years 2024-2028.” This five-year plan builds upon the progress of the previous plan for FY 2019-2023.
FDA Supports Innovation in Animal Biotechnology, Veterinary Products, Food for Animals Through New Comprehensive Agenda
The U.S. Food and Drug Administration announced it is taking new steps to further modernize its approach to evaluating and supporting the development of innovative animal and veterinary products, to increase regulatory flexibility, predictability and efficiency.